Skip to main content
OpenTrials
Completed

NCT Number: NCT01751061

Improving Decision Making for Patients With Prolonged Mechanical Ventilation

Deciding about prolonged life support for critically ill patients can be very difficult. Therefore, the investigators are doing a study to see if an internet-based decision aid can improve the quality of decision making for substitute decision makers of patients who are in the intensive care unit (ICU).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of North Carolina, Chapel Hill, North Carolina, United States

Loading trial locations.

About this study

The process of making a decision about whether or not to provide prolonged life support is seriously deficient among clinicians and the surrogate decision makers for critically ill patients. To address this problem, we propose a randomized, controlled trial to determine if an innovative web-based decision aid compared to usual care control can improve the quality of decision making (defined as clinician-surrogate concordance for prognosis, quality of communication, and medical comprehension), reduce surrogates' psychological distress (depression, anxiety, and post-traumatic stress syndrome disorder (PTSD) symptoms), and reduce patients' health care costs over 6-month follow up. We will enroll 410 surrogate decision makers for 273 patients (expected average of 1.5 surrogates per patient). This study has the potential both to improve how clinicians and surrogates interact in intensive care units and to increase the likelihood that life support decisions are aligned with patients' values.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(Patient characteristics required for surrogate inclusion)

  • age ≥18
  • ≥10 days of mechanical ventilation interrupted by <96 continuous hours of unassisted breathing (including invasive and non-invasive ventilation)
  • no anticipation of imminent (24 hours) death or extubation by the attending.

Exclusion criteria

(Patient characteristics that will exclude surrogates from study enrollment):

  • possession of decisional capacity
  • no identifiable surrogate, surrogate is unavailable for study procedures such as interviews
  • imminent organ transplantation
  • chronic neuromuscular disease
  • physician refuses permission to approach family and/or patient for consent
  • admission for severe burns
  • admission for high cervical spine injury
  • ventilation for >21 days.

Inclusion criteria

for surrogate decision makers:

  • age ≥18
  • self-identified as participating directly in health care decision making for the incapable patient under relevant state law

Exclusion criteria

for surrogate decision makers:

  • do not personally know the patient
  • need translation assistance because of poor English fluency (the decision aid has not been validated in other languages)
  • history of clinically important neurological disorder (e.g., dementia)
  • patient dies after meeting inclusion criteria but before surrogates provide consent

Physician and nurse inclusion criteria:

  • ICU attending or fellow (physicians) at the time of surrogate enrollment
  • bedside ICU nurse present at the time of surrogate enrollment

Treatment and study plan

Decision aid

Behavioral

A web-based decision aid to assist surrogate decision makers in prolonged mechanical ventilation decisions

Usual Care

Other

usual ICU care

Primary outcomes

  1. Change in Clinician-surrogate Concordance Scale Score

    Time frame: ~2-7 days post-randomization

    Concordance is calculated as the absolute value of the difference in prognosis for 1 year patient survival between the surrogate(s) and the clinician (ICU physician), and, therefore, can range from 0 to 100.

    We report pre-intervention to post-intervention difference in the CSCS.

    The CSCS is calculated as the absolute value of the difference between the surrogate's response and that of either the treating ICU physician (primary outcome) or the nurse (secondary outcome) to the question, "What percent chance do you think [the patient/your loved one] has of being alive 1 year from now if the current treatment plan is continued?" Scores can range from 0 to 100 percentage points, and higher values indicate greater discordance.

Secondary outcomes

  1. Hospital Anxiety and Depression Scale (HADS) Total Score

    Time frame: Pre-randomization (study day 1) and 180 days post-randomization

    We report here the difference between Interview 1 (baseline) and Interview 4 (6 months post-randomization) for primary surrogate decision makers (not secondary).

    HADS scores can range from 0 to 42 points; higher scores=more distress.

  2. Post-traumatic Stress Syndrome Inventory

    Time frame: Pre-randomization (study day 1) and 180 days post-randomization

    Here we report PTSS score differences between Interview 1 (baseline) and Interview 4 (6 months post-randomization) for primary (not secondary) surrogate decision makers.

    PTSS scores can range from 10-70, with greater scores=more distress.

  3. Patient-centeredness of Care Scale

    Time frame: Study day 1 and 180 days post-randomization

    Here we report change in patient-centeredness score between Study day 1 (Interview 1) and 180 days post-randomization (Interview 4) for primary (not secondary) surrogate decision makers.

    Scores can range from 12-48 points, with higher scores=greater patient-centeredness.

  4. Medical Comprehension Scale Score

    Time frame: Study day 1 (pre-randomization), ~2-7

    Here we report MCS score differences between Interview 1 (baseline) and Interview 2 (immediately post-intervention) for primary (not secondary) surrogate decision makers.

    Scores can range from 0-8, with greater scores=better comprehension.

  5. Quality of Communication Scale Score

    Time frame: Study day 1 (pre-randomization), ~2-7

    Here we report QOC score differences between Interview 1 (baseline) and Interview 2 (immediately post-intervention) for primary (not secondary) surrogate decision makers.

    Scores range from 0-110, with higher scores=better quality of communication.

  6. Change in Clinical-surrogate Concordance Scale Score (Nurse)

    Time frame: ~2-7 days post-randomization

    Concordance is calculated as the absolute value of the difference in prognosis for 1 year patient survival between the primary surrogate decision maker and the IUC nurse, and, therefore, can range from 0 to 100.

    We report pre-intervention to post-intervention difference in the CSCS.

    The CSCS is calculated as the absolute value of the difference between the surrogate's response and that of the nurse to the question, "What percent chance do you think [the patient/your loved one] has of being alive 1 year from now if the current treatment plan is continued?" Scores can range from 0 to 100 percentage points, and higher values indicate greater discordance.

Sponsors and collaborators

Lead sponsor

Duke University

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)
  • University of North Carolina, Chapel Hill
  • University of Pittsburgh
  • University of Washington

Registry information

Important dates

Study start
2013
Primary completion
2016
Study completion
2017
First posted
Dec 17, 2012
Registry last updated
May 2, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.